Triplet Therapy, Transplantation, and Maintenance until Progression in MyelomaPaul G. Richardson, Irene M. Ghobrial, Edward N. Libby et al.|New England Journal of Medicine|2022Cited by 457
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort studyNarendranath Epperla, Reem Karmali, Lei Feng et al.|Journal of Hematology & Oncology|2023Cited by 52
Impact of extramedullary multiple myeloma on outcomes with idecabtagene vicleucelSaurabh Zanwar, Doris K. Hansen, Surbhi Sidana et al.|Journal of Hematology & Oncology|2024Cited by 46
T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell TherapyKai Rejeski, Roni Shouval, Jaime Sanz et al.|Blood|2025Cited by 31